CO-PROMOTION AGREEMENT by and between TYME TECHNOLOGIES, INC. And EAGLE PHARMACEUTICALS, INC. January 7, 2020Co-Promotion Agreement • March 2nd, 2020 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 2nd, 2020 Company Industry JurisdictionThis Co-Promotion Agreement (this “Agreement”) is entered into and dated as of January 7, 2020 (the “Effective Date”) by and between Tyme Technologies, Inc., a Delaware corporation (“TYME”), and Eagle Pharmaceuticals, Inc., a Delaware corporation (“Eagle”). TYME and Eagle are each referred to individually as a “Party” and together as the “Parties”.
FIFTH AMENDMENT TO LEASEEagle Pharmaceuticals, Inc. • March 2nd, 2020 • Pharmaceutical preparations
Company FiledMarch 2nd, 2020 Industry
SETTLEMENT AGREEMENTSettlement Agreement • March 2nd, 2020 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 2nd, 2020 Company Industry JurisdictionThis SETTLEMENT AGREEMENT (this “Agreement”) is hereby entered into and made effective as of the date it has been executed by all parties hereto (the “Effective Date”) by and between Eli Lilly and Company (“Lilly”) and Eagle Pharmaceuticals, Inc. (“Eagle”). Lilly and Eagle are referred to herein individually as a “Party” and collectively, as the “Parties.”